Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neoplasms × Cryosurgery × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 11 Breast Neoplasms 7 Lung Neoplasms 6 Liver Neoplasms 6 Carcinoma, Hepatocellular 5 Prostatic Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Sarcoma 3 Pain 3 Melanoma 3 Keratosis, Actinic 3 Carcinoma, Renal Cell 3 Small Cell Lung Carcinoma 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Cholangiocarcinoma 2 Biliary Tract Neoplasms 2 Wilms Tumor 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Tongue Neoplasms 1 Spinal Cord Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms, Second Primary 1

Interventions

Gemcitabine 90 Paclitaxel 79 Carboplatin 71 Bevacizumab 70 Surveys and Questionnaires 62 Docetaxel 60 pembrolizumab 59 Cisplatin 58 Capecitabine 46 Exercise 42 Cyclophosphamide 42 Nivolumab 38 Sorafenib 37 Irinotecan 37 Fluorouracil 37 Pemetrexed 33 Dexamethasone 32 Blood Specimen Collection 30 Radiotherapy 29 Oxaliplatin 29 Leucovorin 27 Erlotinib Hydrochloride 27 Albumin-Bound Paclitaxel 26 Cetuximab 25 Doxorubicin 24 130-nm albumin-bound paclitaxel 24 Methods 23 trametinib 22 Sunitinib 22 Standard of Care 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01307501 2021-07-19

ECLIPSE

Boston Scientific Corporation

Phase NA Completed

40 enrolled 19 charts

Lung Neoplasms, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡